Chonluten vs Thymalin
Comparison of Chonluten (Low evidence) and Thymalin (Moderate evidence).
Last updated: February 12, 2026
Chonluten
Thymalin
Overview
Chonluten and Thymalin are both studied in the peptide research space.
Chonluten: A synthetic tripeptide (Glu-Asp-Gly) developed by Vladimir Khavinson for gastrointestinal tissue support.
Thymalin: A thymic peptide complex developed in Russia and used clinically in the former Soviet Union for immunomodulation.
Evidence Comparison
| Aspect | Chonluten | Thymalin |
|---|---|---|
| Evidence Level | Low | Moderate |
| Human Studies | 1 | 8 |
| Preclinical Studies | 6 | 22 |
| Total Sources | 8 | 30 |
Key Differences
| Aspect | Chonluten | Thymalin |
|---|---|---|
| Category | Other | Immune |
| Evidence Strength | Low | Moderate |
| Total Sources | 8 | 30 |
| Human Studies | 1 | 8 |
Summary
- Chonluten: Low evidence with 8 total sources (1 human)
- Thymalin: Moderate evidence with 30 total sources (8 human)
This comparison is for educational purposes only and is not medical advice. Consult a healthcare professional before making any decisions about peptide use.
View Full Dossiers
Stay Updated on Peptide Comparisons
Get notified when we publish new comparison dossiers and evidence reviews.
No spam. Unsubscribe anytime.
Disclaimer: This comparison is for educational purposes only and does not constitute medical advice. Individual responses to medications vary. Always consult a qualified healthcare provider before making treatment decisions.